Evidence map›Paper›PMID 40430914›Full record

ReviewPharmaceutics2025

Aspects and Implementation of Pharmaceutical Quality by Design from Conceptual Frameworks to Industrial Applications.

Shiwei Yang, Xingming Hu, Jinmiao Zhu, Bin Zheng, Wenjie Bi, Xiaohong Wang, Jialing Wu, Zimeng Mi, Yifei Wu

Abstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Pharmaceutics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Review
  6. Article
  7. Review
  8. Review
  9. Review
  10. Review
  11. Review
  12. Review
  13. Article
  14. Review
  15. Review
  16. Review
  17. Article
  18. Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Shiwei YangDepartment of Chemistry and Chemical Engineering, Hefei Normal University, Hefei 230061, China.ORCID 0000-0001-6593-5235
Xingming HuDepartment of Chemistry and Chemical Engineering, Hefei Normal University, Hefei 230061, China.
Jinmiao ZhuDepartment of Chemistry and Chemical Engineering, Hefei Normal University, Hefei 230061, China.
Bin ZhengDepartment of Chemistry and Chemical Engineering, Hefei Normal University, Hefei 230061, China.ORCID 0000-0002-2906-0125
Wenjie BiDepartment of Chemistry and Chemical Engineering, Hefei Normal University, Hefei 230061, China.
Xiaohong WangDepartment of Chemistry and Chemical Engineering, Hefei Normal University, Hefei 230061, China.
Jialing WuDepartment of Chemistry and Chemical Engineering, Hefei Normal University, Hefei 230061, China.
Zimeng MiDepartment of Chemistry and Chemical Engineering, Hefei Normal University, Hefei 230061, China.
Yifei WuDepartment of Chemistry and Chemical Engineering, Hefei Normal University, Hefei 230061, China.

Funding

Key Projects of Scientific Re-search Program of Higher Education Institutions in Anhui Province (2024AH051591, 2023AH051323)
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

design of experimentsdrug developmentquality by design

Identifiers

PMID40430914
PMCPMC12114689

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.